205 related articles for article (PubMed ID: 36129606)
1. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway.
Lu C; Zhang C
Clin Transl Oncol; 2023 Jan; 25(1):160-172. PubMed ID: 36129606
[TBL] [Abstract][Full Text] [Related]
2. The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth.
Liu G; Yang ZF; Sun J; Sun BY; Zhou PY; Zhou C; Guan RY; Wang ZT; Yi Y; Qiu SJ
Cell Oncol (Dordr); 2022 Dec; 45(6):1435-1449. PubMed ID: 36435866
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.
Lau TS; Chung TK; Cheung TH; Chan LK; Cheung LW; Yim SF; Siu NS; Lo KW; Yu MM; Kulbe H; Balkwill FR; Kwong J
J Pathol; 2014 Jan; 232(1):43-56. PubMed ID: 24014111
[TBL] [Abstract][Full Text] [Related]
4. Rocuronium bromide suppresses esophageal cancer via blocking the secretion of C-X-C motif chemokine ligand 12 from cancer associated fibroblasts.
Li J; Gu X; Wan G; Wang Y; Chen K; Chen Q; Lu C
J Transl Med; 2023 Apr; 21(1):248. PubMed ID: 37029408
[TBL] [Abstract][Full Text] [Related]
5. CAFs-secreted exosomal cricN4BP2L2 promoted colorectal cancer stemness and chemoresistance by interacting with EIF4A3.
Qu Z; Yang KD; Luo BH; Zhang F
Exp Cell Res; 2022 Sep; 418(2):113266. PubMed ID: 35752345
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
7. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
[TBL] [Abstract][Full Text] [Related]
8. Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis.
Zhou L; Li J; Tang Y; Yang M
J Transl Med; 2021 Jan; 19(1):8. PubMed ID: 33407563
[TBL] [Abstract][Full Text] [Related]
9. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis.
Liu G; Sun J; Yang ZF; Zhou C; Zhou PY; Guan RY; Sun BY; Wang ZT; Zhou J; Fan J; Qiu SJ; Yi Y
Cell Death Dis; 2021 Mar; 12(3):260. PubMed ID: 33707417
[TBL] [Abstract][Full Text] [Related]
11. The miR-1290/OGN axis in ovarian cancer-associated fibroblasts modulates cancer cell proliferation and invasion.
Jiang B; Xiao S; Zhang S; Xiao F
J Ovarian Res; 2024 Feb; 17(1):52. PubMed ID: 38402185
[TBL] [Abstract][Full Text] [Related]
12. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
13. [Human colorectal cancer cells induce fibroblasts to secrete stromal cell-derived factor 1 (SDF-1) to stimulate cancer cell migration].
Li L; Zhai Y; Wang Y; Yang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):821-827. PubMed ID: 34533130
[TBL] [Abstract][Full Text] [Related]
14. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
16. Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling.
Zhao ZX; Zhang YQ; Sun H; Chen ZQ; Chang JJ; Wang X; Wang X; Tan C; Ni SJ; Weng WW; Zhang M; Wang L; Huang D; Feng Y; Sheng WQ; Xu MD
Acta Pharmacol Sin; 2023 Jan; 44(1):178-188. PubMed ID: 35676532
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5.
Li Z; Zhou J; Zhang J; Li S; Wang H; Du J
Int J Cancer; 2019 Oct; 145(7):1946-1957. PubMed ID: 30873585
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblast (CAF) secretomes-induced epithelial-mesenchymal transition on HT-29 colorectal carcinoma cells associated with hepatocyte growth factor (HGF) signalling.
Wanandi SI; Hilbertina N; Siregar NC; Abdullah M; Jeo WS
J Pak Med Assoc; 2021 Feb; 71(Suppl 2)(2):S18-S24. PubMed ID: 33785936
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
Aizawa T; Karasawa H; Funayama R; Shirota M; Suzuki T; Maeda S; Suzuki H; Yamamura A; Naitoh T; Nakayama K; Unno M
Cancer Med; 2019 Oct; 8(14):6370-6382. PubMed ID: 31468733
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-204 Inhibits the Growth and Motility of Colorectal Cancer Cells by Downregulation of CXCL8.
Shuai F; Wang B; Dong S
Oncol Res; 2018 Sep; 26(8):1295-1305. PubMed ID: 29402343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
